Showing results (41-50 of 83) with videos related to
Sort By:
Pageof 9
Journal of Analytical Toxicology|May 20, 2014
Urinary hydrocodone and metabolite distributions in pain patientsNeveen H Barakat, Rabia S Atayee, Brookie M Best, et al.Journal of Analytical Toxicology|October 2, 2013
Urine specimen detection of concurrent nonprescribed medicinal and illicit drug use in patients prescribed buprenorphineAlexander Y Guo, Joseph D Ma, Brookie M Best, et al.Scientific Reports|November 23, 2019
Proton-pump inhibitor use is associated with a broad spectrum of neurological adverse events including impaired hearing, vision, and memoryTigran Makunts, Sama Alpatty, Kelly C Lee, et al.Journal of Analytical Toxicology|January 8, 2014
Observations on the urine metabolic profile of codeine in pain patientsDavid A Yee, Rabia S Atayee, Brookie M Best, et al.Journal of Analytical Toxicology|February 4, 2014
Factors affecting carisoprodol metabolism in pain patients using urinary excretion dataStephanie A Tse, Rabia S Atayee, Joseph D Ma, et al.Journal of Analytical Toxicology|February 14, 2014
Observations of urinary oxycodone and metabolite distributions in pain patientsNatalie M Elder, Rabia S Atayee, Brookie M Best, et al.Postgraduate Medicine|November 19, 2016
Patterns of naloxone use in hospitalized patientsLisa Yung, Kelly C Lee, Chih Hsu, et al.Mayo Clinic Proceedings|March 23, 2017
Clinical Interpretation of Urine Drug Tests: What Clinicians Need to Know About Urine Drug ScreensKaren E Moeller, Julie C Kissack, Rabia S Atayee, et al.Journal of Palliative Medicine|August 23, 2023
Palliation of Intractable Cancer-Related Pain With Low-Dose Epidural BupivacaineKathryn D Winters, Jennifer Byrne, Natasha Eckholm, et al.Journal of Analytical Toxicology|April 19, 2012
Evaluating the relationship between carisoprodol concentrations and meprobamate formation and inter-subject and intra-subject variability in urinary excretion data of pain patientsStephanie A Tse, Rabia S Atayee, Brookie M Best, et al.Pageof 9